TEAM
Shane Neetichow
- Director
- Asia

- Profile
-
Shane joined Advantage Partners in August 2021.
He is a member of the investment team which is responsible for ITS Science & Medical, Pharmaforte, and Winsome Green. He is engaged in executing investments and providing management support under the Asia Buyout strategy, with a focus on Southeast Asia. He is actively involved across the healthcare, consumer, industrial, and business services sectors.
Shane began his career at J.P. Morgan and UBS Investment bank before transitioning to management consulting at Bain & Company, where he worked across Southeast Asia and New York City. He earned a Bachelor’s degree (Honours) with a Major in Finance from the University of British Columbia and a Master’s degree in Finance from the University of Cambridge. He is fluent in English and Thai.
PORTFOLIO that Shane Neetichow (Director) was involved in

ITS Science & Medical Pte Ltd.

ITS Science & Medical Pte Ltd.
- Name of company
- ITS Science & Medical Pte Ltd.
- Investment date
- August 2025.
- Type of company
- Private
- Background
- Founder / Owner Succession
- Fund
- Asia Fund Ⅱ
- Product
- Asia
- Case Types
- Founder/Owner Succession
- Industry
- Healthcare
- Status
- Current
Responsible Team
Related NEWS

Winsome Green

Winsome Green
- Name of company
- Winsome Green Co., Ltd
- Investment date
- September 2021
- Type of company
- Private
- Background
- Founder / Owner Succession
- Fund
- Asia Fund Ⅰ
- Product
- Asia
- Case Types
- Founder/Owner Succession
- Industry
- Consumables / Retail / Distribution / Manufacturing
- Status
- Current
Responsible Team
Related NEWS

Pharmaforte (Malaysia) / Pharmaforte Singapore

Pharmaforte (Malaysia) / Pharmaforte Singapore
- Name of company
- Pharmaforte (Malaysia) Sdn. Bhd. / Pharmaforte Singapore Pte Ltd
- Investment date
- January 2021
- Type of company
- Private
- Background
- Founder / Owner Succession
- Fund
- Asia Fund Ⅰ
- Product
- Asia
- Case Types
- Founder/Owner Succession
- Industry
- Healthcare / Consumables / Retail / Distribution
- Status
- Current